Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer

NCT00622466 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Study sponsor requested that the study be permanently closed by letter.

Conditions

Breast Cancer

Interventions

DRUG: paclitaxel
DRUG: sorafenib tosylate

Sponsor

University of Texas Southwestern Medical Center